Table 3.
10 mg/kg | 15 mg/kg | 15 vs 10 p value | 20 mg/kg | 20 vs 10 p value | Control group | |
---|---|---|---|---|---|---|
SAEs | ||||||
Number of children ever having an SAE | 3 (9%) | 3 (9%) | 1.00 | 4 (11%) | 1.00 | 2 (4%) |
Number of SAEs | 3 | 3 | 4 | 2 | ||
SAE criteria | ||||||
Fatal | 1 (33%) | 1 (33%) | 1 (25%) | 0 (0%) | ||
Life-threatening | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Caused or prolonged hospitalisation | 2 (67%) | 2 (67%) | 3 (75%) | 2 (100%) | ||
Persistent or significant disability/incapacity | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Other important medical condition | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
No further grade 3/4 AEs were reported that were not SAEs. No SAEs were judged to be related to azithromycin, the dose of azithromycin, or lead to a change in azithromycin